印度生物制品的监管演变:全球领导的创新差距和战略要求
Anshuman Panda1, Biswa Mohan Sahoo1, Chandan Kumar Brahma1
1School of Pharmacy and Life Sciences, Centurion University of Technology & Management, Jatni, Khurda-752050, Odisha, India.
Current drug discovery technologies
|March 14, 2026
概括
印度 印度 印度
科学领域:
- 生物制品和制药条例 生物制品和制药条例
- 生物技术和医疗保健标准 生物技术和医疗保健标准
背景情况:
- 生物制品是从生物体中提取的,包括一系列产品,包括疫苗,血液成分和基因疗法.
- 确保这些重要医疗产品的安全性,有效性和质量对于公共卫生至关重要.
研究的目的:
- 概述印度生物制品制造和进口的监管框架.
- 详细说明关键监管机构和相关立法在生物制品监管中的作用.
主要方法:
- 对生物制剂的印度监管格局的审查.
- 管理机构的识别:中央药品标准控制组织 (CDSCO),生物技术部 (DBT) 和基因操纵审查委员会 (RCGM).
- 1940年药品和化品法案及相关规则的审查 (Y表,44表).
主要成果:
- CDSCO是评估和批准用于制造和进口的生物产品的主要机构.
- DBT和RCGM监督生物开发,临床前研究和转基因生物研究.
- 药品和化品法案规定了新药批准的具体申请程序和数据要求.
结论:
- 印度的生物制品监管体系通过确保安全,有效和优质的产品优先考虑高标准的医疗保健.
- 该框架支持制药行业,同时保护公众健康和患者福祉.
- 遵守诸如附表Y之类的法规对于新的生物药物批准至关重要.
相关概念视频
Drug Products: Biologics, Biosimilars and Interchangeables
342
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
342
Biopharmaceutical Factors Influencing Drug Product Design: Overview
405
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
405
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
519
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
519
Global Regulatory Systems
840
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
840
Drug Control Governance: Regulatory Bodies and Their Impact
638
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
638


